Tardiff Daniel reported CAMP

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002089301-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Apr 1, 2026

Published

Apr 3, 2026

Ingested by INSIDER

Nov 5, 04:07 UTC

Last re-read

Nov 5, 04:07 UTC

Extracted facts

Filer

Tardiff Daniel

Role

Chief Scientific Officer

Transaction

Grant or awardAs filed: “A”

Asset

Camp4 Therapeutics Corp — Stock Option (Right to Buy)

Ticker

CAMP

Shares

170.0K

Price per share

$0

Execution date (reported)

Apr 1, 2026

Owned after transaction

170.0K shares

Days from execution to publication

2

What this establishes

Tardiff Daniel filed this Form 4 reporting a grant or award of CAMP on Apr 1, 2026. It became public on Apr 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Scientific Officer

Tardiff Danielcik:0002089301

Issuer

Camp4 Therapeutics Corpcik:0001736730

Revision history · 0

No field has changed since this record was first ingested.